All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

[(p-MeC6H4Pri)2Ru2(SC6H4-p-But)3]Cl (diruthenium-1), a dinuclear arene ruthenium compound with very high anticancer activity: An in vitro and in vivo study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F15%3A10283581" target="_blank" >RIV/00216208:11150/15:10283581 - isvavai.cz</a>

  • Result on the web

    <a href="http://www.sciencedirect.com/science/article/pii/S0022328X1400535X" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0022328X1400535X</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jorganchem.2014.10.050" target="_blank" >10.1016/j.jorganchem.2014.10.050</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    [(p-MeC6H4Pri)2Ru2(SC6H4-p-But)3]Cl (diruthenium-1), a dinuclear arene ruthenium compound with very high anticancer activity: An in vitro and in vivo study

  • Original language description

    A newly synthesised derivative [(p-MeC6H4Pri)2Ru2(SC6H4-p-But)3]Cl (diruthenium-1) with an IC50 value of only 30 nM for both cisplatin-resistant mutant A2780cisR and the normal A2780 cancer cells, was selected for an in vivo anticancer study using a mouse model. In a solid Ehrlcih tumour, diruthenium-1 at doses of 0.4 and 0.6 mg/kg i.p. inhibited the tumour growth, although somewhat less than cisplatin (5 mg/kg i.p.) in the positive control group. However, it was only diruthenium-1 at a dose of 0.6 mg/kg that prolonged significantly the survival rate of the tumour-bearing mice as compared to the untreated control group. A biodistribution study by ICP-MS showed ruthenium to be present in the tumour and particularly in the excretion organs but not in thebrain; the elimination half-life of diruthenium-1 was estimated to be approximately 30 h. In MCF-7 and BT-549 cells, diruthenium-1 exhibited antiproliferative and cytotoxic effects, stimulated the expression and phosphorylation of p53, a

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    CE - Biochemistry

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Organometallic Chemistry

  • ISSN

    0022-328X

  • e-ISSN

  • Volume of the periodical

    782

  • Issue of the periodical within the volume

    April

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    10

  • Pages from-to

    42-51

  • UT code for WoS article

    000351637900008

  • EID of the result in the Scopus database

    2-s2.0-84925431451